1. Home
  2. IMMX vs TASK Comparison

IMMX vs TASK Comparison

Compare IMMX & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$7.96

Market Cap

784.8M

Sector

Health Care

ML Signal

HOLD

TASK

TaskUs Inc.

SELL

Current Price

$8.22

Market Cap

755.5M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
IMMX
TASK
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
755.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IMMX
TASK
Price
$7.96
$8.22
Analyst Decision
Strong Buy
Hold
Analyst Count
7
8
Target Price
★ $24.30
$8.50
AVG Volume (30 Days)
★ 1.6M
413.5K
Earning Date
11-06-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 120.00
EPS
N/A
★ 0.50
Revenue
N/A
N/A
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
$6.42
P/E Ratio
★ N/A
$17.04
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$4.47
52 Week High
$15.10
$14.36

Technical Indicators

Market Signals
Indicator
IMMX
TASK
Relative Strength Index (RSI) 27.55 52.09
Support Level $7.96 $7.50
Resistance Level $10.61 $8.29
Average True Range (ATR) 0.59 0.30
MACD -0.17 -0.01
Stochastic Oscillator 1.73 42.29

Price Performance

Historical Comparison
IMMX
TASK

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

Share on Social Networks: